Better targeted treatments for 20 percent of renal failure patients are on the horizon following a key discovery about the role of white blood cells in kidney inflammation.
Better targeted treatments for 20 percent of renal failure patients are on the horizon following a key discovery about the role of white blood cells in kidney inflammation.